chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I administered the first dose of the Moderna Covid vaccine to a 16 year old patient on August 11, 2021. No adverse reactions or symptoms have been reported.
A moderate amount of LDA arteriosclerosis around the heart; shortness of breath; Fast heart rate, rapid heart beat related to drop in sugar levels; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Fast heart rate, rapid heart beat related to drop in sugar levels), ARTERIOSCLEROSIS (A moderate amount of LDA arteriosclerosis around the heart) and DYSPNOEA (shortness of breath) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced TACHYCARDIA (Fast heart rate, rapid heart beat related to drop in sugar levels). On an unknown date, the patient experienced ARTERIOSCLEROSIS (A moderate amount of LDA arteriosclerosis around the heart) and DYSPNOEA (shortness of breath). On 19-Feb-2021, TACHYCARDIA (Fast heart rate, rapid heart beat related to drop in sugar levels) had resolved. At the time of the report, ARTERIOSCLEROSIS (A moderate amount of LDA arteriosclerosis around the heart) and DYSPNOEA (shortness of breath) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: abnormal abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient needs to have an operation for their rotator cuff, but is not able until they get clearance from their cardiologist..  No relevant concomitant medications were reported. Treatment information for the event was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: New events added.
Body aches after first dose; Body Malaise after first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches after first dose) and MALAISE (Body Malaise after first dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0141720A, 006B21A and 012F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN (Body aches after first dose) and MALAISE (Body Malaise after first dose). At the time of the report, PAIN (Body aches after first dose) and MALAISE (Body Malaise after first dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No Concomitant medications were reported. No Treatment mediations were reported.
Patient reported temperature of 103 and chills for about 4 hours about 12 hours after administration. She took acetaminophen and it eased the symptoms.
teeth sensitive to the cold / front teeth felt like she was eating ice cream; teeth felt like they were tingling; middle, upper, and lower areas of her jaw ache; food tastes bitter; upper right side ached / ached / ache slowly became more pronounced / strong ache; This spontaneous case was reported by a consumer and describes the occurrence of GINGIVAL PAIN (teeth sensitive to the cold / front teeth felt like she was eating ice cream), MYALGIA (upper right side ached / ached / ache slowly became more pronounced / strong ache), DENTAL PARAESTHESIA (teeth felt like they were tingling), PAIN IN JAW (middle, upper, and lower areas of her jaw ache) and DYSGEUSIA (food tastes bitter) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GINGIVAL PAIN (teeth sensitive to the cold / front teeth felt like she was eating ice cream), MYALGIA (upper right side ached / ached / ache slowly became more pronounced / strong ache), DENTAL PARAESTHESIA (teeth felt like they were tingling), PAIN IN JAW (middle, upper, and lower areas of her jaw ache) and DYSGEUSIA (food tastes bitter). At the time of the report, DENTAL PARAESTHESIA (teeth felt like they were tingling), PAIN IN JAW (middle, upper, and lower areas of her jaw ache) and DYSGEUSIA (food tastes bitter) outcome was unknown.
Swelling; This case was reported by a physician via call center representative and described the occurrence of swelling arm in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced swelling arm. On an unknown date, the outcome of the swelling arm was unknown.   It was unknown if the reporter considered the swelling arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that the patient received the Shingrix vaccine and experienced swelling of her whole upper arm. Unable to obtain additional details. This is 1 of 3 cases reported by same reporter.
Headache; fatigue; irritable bowels; diarrhea; nausea; stomach cramps/stomach pain; arm soreness; kidney pain; the first dose of BNT162B2 was administered in the left leg; This is a spontaneous report from a non-contactable pharmacist, the patient.  A 29-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284), via an unspecified route of administration in the left leg on 23Dec2020 at 13:00 (at the age of 29-years old) as a single dose for COVID-19 immunization.  Medical history included gastrooesophageal reflux disease.  The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 01Jan2021 at 15:00, the patient experienced headache, fatigue, irritable bowels, diarrhea, nausea, stomach cramps/stomach pain, arm soreness, and kidney pain.  The patient took lopearmde (MANUFACTURER UNKNOWN), sucralafate (MANUFACTURER UNKNOWN), and calcium carbonate (TUMS) as treatment. The clinical outcomes of the headache, fatigue, irritable bowels, diarrhea, nausea, stomach cramps/stomach pain, arm soreness, and kidney pain were not recovered. It was reported that the patient received the second dose of the BNT162B2 on 11Jan2021 (at the age of 29-years old; Lot Number: EL3302) in the right arm.   No follow-up attempts are possible. No further information is expected.
Pt. reported itching, red raised areas (L) and (R) wrists inner (L) and (R) thighs.
one knuckle from index finger of right hand is red; experiencing a side effect from the vaccine; one knuckle from index finger of right hand is painful / just keeps getting worse each day/ it's progressing to the other knuckle of right hand as well; headache behind eyes after the 1st shot; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (one knuckle from index finger of right hand is red), VACCINATION COMPLICATION (experiencing a side effect from the vaccine), ARTHRALGIA (one knuckle from index finger of right hand is painful / just keeps getting worse each day/ it's progressing to the other knuckle of right hand as well) and HEADACHE (headache behind eyes after the 1st shot) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     Concurrent medical conditions included Tinnitus. Concomitant products included OMEPRAZOLE for Acid reflux (oesophageal), MELOXICAM for an unknown indication.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (one knuckle from index finger of right hand is red), VACCINATION COMPLICATION (experiencing a side effect from the vaccine), ARTHRALGIA (one knuckle from index finger of right hand is painful / just keeps getting worse each day/ it's progressing to the other knuckle of right hand as well) and HEADACHE (headache behind eyes after the 1st shot). The patient was treated with IBUPROFEN at an unspecified dose and frequency; ACETYLSALICYLIC ACID (ASPEN [ACETYLSALICYLIC ACID]) at an unspecified dose and frequency and BENZOCAINE (LANACANE [BENZOCAINE]) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (one knuckle from index finger of right hand is red), VACCINATION COMPLICATION (experiencing a side effect from the vaccine), ARTHRALGIA (one knuckle from index finger of right hand is painful / just keeps getting worse each day/ it's progressing to the other knuckle of right hand as well) and HEADACHE (headache behind eyes after the 1st shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drug included BP Pills. Treatment included CBD Cream.
Initial dose given was thought to be air in syringe. Following CDC for doses given that are less than 50% a full dose was given in opposite arm.
Severe pain localized in center of left shoulder. Would last 30 minutes and took my breath away. Lasted several weeks followed by pain of radial nerve localized on left arm, pain concentrated on left wrist. Had to wear splint to immobilize wrist. Total symptoms lasted 4 months and as of 12/1/16 still have some neuropathy in left hand.
This spontaneous case was initially received on 03-Nov-2015. The case report was received from a(n) Health Professional and concerns a(n) 30 years old male patient. Weight: 240 pounds, Height: 74 inches. The patient received AFLURIA on 09-Oct-2015, Batch no: T51608, Route of administration: Intramuscular, Dose: 0.5 ml. No additional drugs suspected. On 09-Oct-2015, the patient received an IM dose of expired AFLURIA.
Moderna COVID-19 Vaccine EUA.  About 56 hours after the injection, I developed a large (4x 6 inches) red, swollen, itchy, and hot patch on the arm about 2 inches below the injection site. It is still there now, about 20 hours later. Its sensitivity varies, mostly with respect to the stinging/itching. It calms down some with analgesic. I took a Claritin at bedtime last night, but I'm not sure it really had any effect. I've read online that this can happen and that it's nothing to worry about, so I'll just wait it out.
2-2 1/2 cm area on upper deltoid to mid humerus redness wrapping around to both sides. Hot to touch. Bottom site bruised.
The day after receiving the vaccine I felt severe nausea and dizziness. My body was aching to the point that I was unable to even do the lightest of my daily activities. I had severe muscle aches and pains. I had fevers in the range from 103.7 to 104.5.  The symptoms continued throughout the day. One week later, I still have muscle pains in various areas of my body.
Rash on my back, is it a mild case of shingles?; This case was reported by a consumer via call center representative and described the occurrence of rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 week after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.     Additional Information: GSK Receipt Date: 8-Nov-2022 Reporter's Comments: The patient self-reported this case. The patient had a rash on his/her back one week after receiving first dose of Shingrix.  The patient wants to know could this be a side effect, was it a mild case of shingles. Additional Supportive Information: The follow up would not possible as no contact details were available.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 at 02:00 as dose 5 (booster), single (Lot number: C-J5352) at the age of 69 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "not recovered" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: 3 days after 5 day Paxlovid treatment and testing covid free; (2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19: Treatment with Paxlovid.
Information has been received on 31-JUL-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 03-FEB-2010, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a medical office as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 17-NOV-2015, the patient was treated at a medical center for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Following the Pfizer BionTech Covid 19 EUA, the Patient complained of rash on arms bilaterally, some anxiety related to rash. Vital signs: 11:05 am BP 148/78 HR, 11:10 am 117/79 HR 69, 11:15am BP 129/80 HR 75,  Benadryl exlir 12.5mg/5mL administered at 11:15am PO. Vital signs: 11:20am BP 133/79 HR 67, 11:30 amBP 124/76 HR 63 Symptons of rash disappered at 11:30am. Vital signs: 11:45am BP 116/77 HR 63 ). Oxygen saturation stayed at 97 -99% the entire time. Patient reported felling fine. Pateint was released to home at 11:45 with spouse driving car.Pt told to follow up with ER or PCP if symptons reoccur.
Vomiting; nausea; temperature=99.2; Body aches; vaccination on 11/11/2009 at 2:00pm. Symptoms started at 9:00pm; "Red" color in vomit; went to hospital; out of school x1 day.
Patient given second dose of COVID-19 vaccine at 9:41am.  Vial being stored in refrigerator had DO NOT USE BEYOND date of 10/14/21 at 0700 am.  Manufacturer (Pfizer) contacted and stated that they have off-label studies showing physical properties of vaccine are unchanged for 32 days.  Medical director consulted and does not advise re-administering vaccine.
Dizziness, NauseaVomiting  HOT FLASHES  Narrative:  22 yo employee who presents to the ER after feeling dizzy, nauseated, and having hot flashes immediately after the Johnson/Johnson vaccine. She reports she did feel nauseated when she saw blood on her arm but thought it was getting better until she went to stand and felt dizzy. Pt denies any vomiting, trouble breathing, throat swelling or wheezing. Was treated with IV fluids, prednisone, famotidine and benydral
headaches; nausea/ feels like she's hoping to throw up; fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches), NAUSEA (nausea/ feels like she's hoping to throw up) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches), NAUSEA (nausea/ feels like she's hoping to throw up) and PYREXIA (fever). At the time of the report, HEADACHE (headaches), NAUSEA (nausea/ feels like she's hoping to throw up) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not  provided.  lab data was not provided. His daughter just got her first moderns dose and is having headache and nausea and fever and feels like she's hoping to throw up. What can she do to help cuz she's at work and not able to leave
Pt reported severe itching rash and swelling on both arms. Had to call doctor to discuss and take steroid creams and BENADRYL.
pt recv vax OCT96 & p/the vax pt exp dizziness & paresthesia;@ the time of the report, sx had lasted for 48hr;
P/each DTP shot pt had extreme fever of 104; Taken to MD then administered PCN shot;noticed pt lay in bed in trance;no sound could disturb;did not realize pt had petit mal until p/ grand mal.
Parsonage turners syndrome; extreme weakness in her shoulder and arm.; extreme pain in her shoulder and arm.; A spontaneous report was received from a consumer concerning a 69-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events parsonage turners syndrome/neuralgic amyotrophy, extreme weakness in her shoulder and arm/muscular weakness, extreme pain in her shoulder and arm/pain in extremity.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 013L20A)  for prophylaxis of COVID-19 infection. No adverse event reported with the first dose of the vaccine.  On unknown date, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 039K20A) for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events developed Parsonage turners syndrome, extreme weakness in her shoulder and arm, extreme pain in her shoulder and arm.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events parsonage turners syndrome, extreme weakness in her shoulder and arm, extreme pain in her shoulder and arm was unknown.
Uncontrolled muscle contractions, eyes roll back, sometimes falls to ground, as often as several times per minute.
thyroid trouble; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of THYROID DISORDER (thyroid trouble) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THYROID DISORDER (thyroid trouble). At the time of the report, THYROID DISORDER (thyroid trouble) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant informations were reported.
No adverse event; Expired vaccine used/ Patients received this Moderna vaccine  expiration date was 07 Apr 2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/ Patients received this Moderna vaccine  expiration date was 07 Apr 2022) and NO ADVERSE EVENT (No adverse event) in a 68-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 07-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/ Patients received this Moderna vaccine  expiration date was 07 Apr 2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/ Patients received this Moderna vaccine  expiration date was 07 Apr 2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/ Patients received this Moderna vaccine  expiration date was 07 Apr 2022).    Patient age was reported as 68 years 10 months. It was reported that lot 070H21A, that has an expiration date of 7-Apr-2022. Patients received this Moderna vaccine between 8-Apr-2022 and 15-Dec-2022. No concomitant medication were reported. No treatment medication were reported.
The next morning after the 2nd dose, I experienced headaches, body sores, tiredness, and fever over 100.4F
I also have COPD; It felt like I had Pneumonia; having trouble breathing; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported), via an unspecified route of administration on 02Apr2021 as single dose for COVID-19 immunization in an hospital. Medical history included pneumonia (had pneumonia many times before) from an unknown date. The patient's concomitant medications were not reported. On 09Apr2021, it was reported that the patient was having trouble breathing. On 12Apr2021, 10 days after, the patient reported "felt like I had pneumonia" and on an unspecified date, reported that "I also have COPD (chronic obstructive pulmonary disease)." The outcome of the events was unknown.  Information on the lot/batch number has been requested.
On 11/28/01 at 12:30, the pt was seen at a local ER. Right upper arm with 2 punctures with red lesion at area around injection site. Pt was treated with antibiotics and stayed overnight.